Jefferies has reiterated its hold recommendation for Essity and has marginally lowered its target price to 252 kronor from the previous 253 kronor, according to a new analysis.

The research firm expects price pressure to persist into 2026, particularly in consumer tissue and baby care segments, where competition is intense and volumes remain weak.

At the same time, lower raw material and energy costs are providing some relief on the cost front, but this is expected to be partially offset by increased marketing investments, the report states.

Jefferies' estimate for organic growth in 2026 has been reduced to 0.9 percent from the previous 3.0 percent, which is below the consensus of 1.1 percent.

The stock is trading at a P/E ratio of around 13 based on 2027 consensus, which Jefferies says indicates that much of the risk related to weaker revenues and margins is already priced in.

Essity shares are unchanged at 270.20 kronor.